310 related articles for article (PubMed ID: 34187697)
1. Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome.
Pouliquen IJ; Austin D; Steinfeld J; Yancey SW
Clin Ther; 2021 Jul; 43(7):1278-1280. PubMed ID: 34187697
[No Abstract] [Full Text] [Related]
2. Hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis: Eosinophilic-associated inflammatory conditions with a challenging diagnosis and treatment.
Konsek-Komorowska SJ; Cygański P
Kardiol Pol; 2022; 80(9):961-963. PubMed ID: 35877194
[No Abstract] [Full Text] [Related]
3. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
[TBL] [Abstract][Full Text] [Related]
4. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
[TBL] [Abstract][Full Text] [Related]
5. [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].
Holle JU; Moosig F
Z Rheumatol; 2023 May; 82(4):307-320. PubMed ID: 37099180
[TBL] [Abstract][Full Text] [Related]
6. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
Akdime F; Puéchal X; Roche N
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2942-2943. PubMed ID: 34246444
[No Abstract] [Full Text] [Related]
7. Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?".
Caminati M; Crisafulli E; Lunardi C; Micheletto C; Festi G; Maule M; Giollo A; Orsolini G; Senna G
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2943-2944. PubMed ID: 34246445
[No Abstract] [Full Text] [Related]
8. [ADVANCES IN DIAGNOSIS AND TREATMENT IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)].
Taniguchi M; Kamide Y; Nakamura Y; Watai K; Fukutomi Y; Sekiya K
Arerugi; 2024; 73(1):26-33. PubMed ID: 38403698
[No Abstract] [Full Text] [Related]
9. Mepolizumab to treat eosinophilic granulomatosis with polyangiitis.
Callejas Rubio JL; Moreno Higueras M; Ortego Centeno N
Med Clin (Barc); 2024 Feb; 162(3):140. PubMed ID: 37567822
[No Abstract] [Full Text] [Related]
10. Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis.
Anai M; Yoshida C; Ozono K; Furukawa H; Ishimaru Y; Sakata S; Saruwatari K; Muramoto K; Tomita Y; Saeki S; Ichiyasu H; Sakagami T
Allergol Int; 2022 Apr; 71(2):259-261. PubMed ID: 35074267
[No Abstract] [Full Text] [Related]
11. Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response.
Bello F; Emmi G; Tamburini C; Maggi L; Annunziato F; Cosmi L; Prisco D
Clin Exp Rheumatol; 2022 May; 40(4):863-864. PubMed ID: 35485409
[No Abstract] [Full Text] [Related]
12. Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review.
Kamide Y; Watai K; Nakamura Y; Iwata M; Fukutomi Y; Taniguchi M; Sekiya K
Allergol Int; 2024 Jan; 73(1):180-183. PubMed ID: 37852914
[No Abstract] [Full Text] [Related]
13. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
[TBL] [Abstract][Full Text] [Related]
14. L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cordier JF; Cottin V; Guillevin L; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME
Presse Med; 2013 Apr; 42(4 Pt 2):507-10. PubMed ID: 23490637
[No Abstract] [Full Text] [Related]
15. Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.
Hayama Y; Tomyo F; Ueno M; Asakawa S; Arai S; Yamazaki O; Tamura Y; Mochizuki M; Ohashi R; Shibata S; Fujigaki Y
Intern Med; 2021 Dec; 60(23):3759-3764. PubMed ID: 34092738
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Groh M; Pagnoux C; Baldini C; Bel E; Bottero P; Cottin V; Dalhoff K; Dunogué B; Gross W; Holle J; Humbert M; Jayne D; Jennette JC; Lazor R; Mahr A; Merkel PA; Mouthon L; Sinico RA; Specks U; Vaglio A; Wechsler ME; Cordier JF; Guillevin L
Eur J Intern Med; 2015 Sep; 26(7):545-53. PubMed ID: 25971154
[TBL] [Abstract][Full Text] [Related]
17. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Uematsu H; Takata S; Sueishi K; Inoue H
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
[TBL] [Abstract][Full Text] [Related]
18. Benralizumab in eosinophilic granulomatosis with polyangiitis.
Laorden D; Romero D; Domínguez-Ortega J
Med Clin (Barc); 2022 May; 158(9):441-442. PubMed ID: 34728088
[No Abstract] [Full Text] [Related]
19. First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis.
Emmi G; Silvestri E; Marconi R; Carrai V; Fanelli T; Zucchini P; Marasca R; Vannucchi AM; Emmi L; Prisco D; Vaglio A
Rheumatology (Oxford); 2015 Sep; 54(9):1751-3. PubMed ID: 26106208
[No Abstract] [Full Text] [Related]
20. Can ANCA differentiate eosinophilic granulomatosis with polyangiitis (Churg-Strauss) from idiopathic hypereosinophilic syndrome?
Zwerina J; Strehl JD; Beyer C; Schett G
Clin Exp Rheumatol; 2013; 31(6):989-90. PubMed ID: 24144017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
